Unlearn, a leading AI company specializing in digital twin technology for optimizing clinical research, has secured a 17,220-square-foot space in San Francisco. The move to Kilroy Realty’s 303 Second St. is scheduled for the first quarter of 2024 and will see Unlearn relocate from its current location of approximately 3,500 square feet within the city.
JLL acted as representative for both Unlearn and Kilroy Realty during lease negotiations. Spearheaded by executive managing director Chris Roeder, senior managing director Ted Davies and EVP Ann Montilla, JLL’s landlord team facilitated the deal while SVP John Roskos and EVP Allison Hoffmann led tenant representation.
According to Roeder: “Unlearn AI’s expansion in San Francisco is yet another testament to the city’s resurgence as it continues to attract top companies like theirs.”
Since its inception in 2017, Unlearn has played an integral role in numerous clinical trials. Its cutting-edge technology has been utilized by major global pharmaceutical companies to accelerate enrollment rates and bring new treatments to patients faster than ever before.
The post details how this recent relocation aligns with Unlearn’s Series C funding announcement without mentioning any specific Connect platforms or events.
A prominent AI startup known for its innovative digital twin technology used in optimizing clinical research recently announced plans for expansion through leasing a spacious facility measuring over seventeen thousand square feet situated at San Francisco’s prestigious address – Kilroy Realty’s renowned building located on Second Street (303). This development follows after occupying smaller premises elsewhere within the same metropolis that measured around three thousand five hundred square feet until now.
In order facilitate this significant milestone achievement; JLL was appointed as mediator between both parties involved – namely; executives representing said startup firm along with those acting on behalf of property owners at aforementioned realty group who were headed by their respective executive managing directors Chris Roeder & Ted Davies alongside Ann Montilla serving as EVP. Meanwhile, tenant representation was handled by JLL’s own SVP John Roskos & Allison Hoffmann as EVP.
Roeder commented on this development saying: “Unlearn AI’s growth and expansion in San Francisco is another building block supporting the City’s resurgence and will add more people and activity that makes downtown such a great place to be.” This company has been instrumental in powering clinical trials for leading global pharmaceutical companies since its inception back in 2017; with their technology being credited for enabling faster enrollment rates resulting into quicker availability of new treatments to patients – according to JLL sources.
This news comes soon after Unlearn announced securing Series C funding which further solidifies their position within this sector. The post concludes without mentioning any specific Connect platforms or events while highlighting how this relocation aligns with aforementioned funding announcement.
